|
Baseline and Dobutamine-Stressed Hemodynamic/Cardiovascular and Metabolic Variables |
||||||
| Survivor Baseline (n = 8) |
Non-survivors Baseline (n = 15) |
P value: survivor vs non-survivor-baseline |
Survivor: change from baseline |
Non-survivor: change from baseline |
P value: survivor vs non-survivor-change from baseline |
|
|
|
||||||
| HR (min-1) |
88.3 ± 5.1 |
106.7 ± 5.7 |
.0254 |
16.1 ± 4.7 |
14.9 ± 4.2 |
.8645 |
| sBP (mmHg) |
124.3 ± 6.8 |
114.0 ± 4.9 |
.2427 |
24.6 ± 12.6 |
8.3 ± 5.2 |
.1630 |
| dBP (mmHg) |
64.1 ± 4.2 |
57.6 ± 2.8 |
.2207 |
-1.6 ± 3.2 |
2.3 ± 2.4 |
.3508 |
| PP (mmHg) |
60.1 ± 6.5 |
56.4 ± 4.7 |
.6541 |
26.3 ± 10.4 |
5.9 ± 4.1 |
.0403 |
| MP (mmHg) |
84.2 ± 4.2 |
76.4 ± 2.8 |
.1391 |
7.1 ± 6.0 |
4.3 ± 3.0 |
.6225 |
| SVI (ml/beat/m2) |
31.5 ± 3.0 |
29.0 ± 3.0 |
.5663 |
16.4 ± 3.7 |
3.0 ± 1.0 |
.0003 |
| CI (L/min/m2) |
2.78 ± 0.32 |
3.01 ± 0.33 |
.5910 |
2.24 ± 0.55 |
0.80 ± 0.22 |
.0093 |
| RAP (mmHg) |
13.6 ± 1.9 |
14.5 ± 1.4 |
.7346 |
-0.8 ± 0.9 |
0.4 ± 0.8 |
.9405 |
| sPAP (mmHg) |
44.6 ± 4.6 |
40.5 ± 2.2 |
.4459 |
3.5 ± 5.1 |
2.2 ± 2.1 |
.6389 |
| dPAP (mmHg) |
22.6 ± 2.9 |
19.5 ± 0.8 |
.3253 |
-5.1 ± 1.8 |
0.6 ± 1.1 |
.0133 |
| PAM (mmHg) |
30.0 ± 3.3 |
26.5 ± 0.9 |
.3494 |
-2.3 ± 2.5 |
1.1 ± 1.2 |
.2442 |
| PWP (mmHg) |
19.8 ± 2.8 |
17.6 ± 1.1 |
.4896 |
-1.8 ± 1.4 |
-1.1 ± 0.8 |
.5829 |
| PAO2 (mmHg) |
95.6 ± 12.2 |
97.5 ± 9.4 |
.9034 |
-2.3 ± 8.2 |
-12.2 ± 9.2 |
.4518 |
| PACO2 (mmHg) |
35.6 ± 1.5 |
32.0 ± 2.3 |
.2000 |
-1.4 ± 0.9 |
-0.3 ± 0.8 |
.3846 |
| O2sat (%) |
95.2 ± 1.2 |
96.0 ± 0.7 |
.4750 |
-0.6 ± 1.2 |
-1.0 ± 0.7 |
.6463 |
| MVO2 (% |
62.3 ± 3.7 |
62.1 ± 2.8 |
.9879 |
8.8 ± 2.0 |
2.0 ± 1.6 |
.0234 |
| LVEF (%) |
50 ± 5 |
57 ± 4 |
.3184 |
11.8 ± 3.8 |
1 ± 2 |
.0160 |
| LVEDVI (mLm2) |
65.2 ± 6.5 |
52.7 ± 5.8 |
.1691 |
19.9 ± 7.4 |
7.8 ± 5.4 |
.1987 |
| LVESVI (mL/m2) |
33.6 ± 6.7 |
23.0 ± 4.4 |
.2535 |
3.5 ± 6.5 |
5.1 ± 5.0 |
.8497 |
| LVSWI (g.m/m2) |
28.3 ± 4.1 |
22.9 ± 2.3 |
.2567 |
22.3 ± 7.1 |
5.2 ± 1.4 |
.0054 |
| SVRI (dynes/sec/cm2/m2) |
2232 ± 314 |
1835 ± 170 |
.2728 |
-901 ± 246 |
-162 ± 150 |
.0154 |
| RVEF (%) |
65 ± 3 |
64 ± 4 |
.8489 |
4.8 ± 4.1 |
2.9 ± 2.5 |
.6793 |
| RVEDVI (mL/m2) |
48.4 ± 4.2 |
46.1 ± 4.7 |
.7194 |
25.2 ± 8.8 |
1.7 ± 2.6 |
.0047 |
| RVESVI (mL/m2) |
16.8 ± 2.6 |
17.4 ± 3.0 |
.8874 |
8.7 ± 6.7 |
-1.0 ± 2.4 |
.1125 |
| RVSWI (g.m/m2) |
6.8 ± 1.1 |
4.5 ± 0.6 |
.0916 |
1.8 ± 0.7 |
1.4 ± 0.6 |
.4365 |
| PVRI (dynes/sec/cm2/m2) |
322 ± 50 |
263 ± 45 |
.3910 |
-147 ± 39 |
-21.0 ± 32 |
.0390 |
| CaO2 (mL/dL) |
13.4 ± 1.0 |
12.8 ± 0.5 |
.6190 |
-0.1 ± 0.2 |
-0.1 ± 0.1 |
.8551 |
| CvO2 (mL/dL) |
8.6 ± 0.6 |
8.4 ± 0.6 |
.8161 |
1.3 ± 0.4 |
0.3 ± 0.2 |
.0208 |
| DO2I (mL/min/m2) |
352 ± 24 |
383 ± 45 |
.5448 |
301 ± 78 |
98 ± 29 |
.0084 |
| VO2I (mL/min/m2) |
122 ± 10 |
122 ± 6 |
.9967 |
32 ± 10 |
22 ± 7 |
.3652 |
| sbp/lvesvi (mm Hg/mL/m2) |
4.57 ± 0.73 |
7.33 ± 1.51 |
.1152 |
3.12 ± 1.32 |
0.15 ± 0.5 |
.0188 |
| PAS/rvesvi (mm Hg/mL/m2) |
3.06 ± 0.44 |
3.21 ± 0.51 |
.8255 |
0.69 ± 0.69 |
0.71 ± 0.90 |
.9877 |
| lvedvi/pwp (mL/m2/mmHg) |
3.82 ± 0.67 |
3.18 ± 0.38 |
.4123 |
1.52 ± 0.47 |
0.74 ± 0.35 |
.1964 |
| RVEDVI/RAP (mL/m2/mmHg) |
4.24 ± 0.89 |
3.44 ± 0.40 |
.4288 |
3.63 ± 2.34 |
0.23 ± 0.46 |
.0783 |
| pH |
7.38 ± 0.3 |
7.41 ± 0.02 |
.3988 |
0 ± 0.01 |
0 ± 0.01 |
.8820 |
| Qs/QT |
0.11 ± 0.02 |
0.11 ± 0.02 |
.8990 |
0.07 ± 0.05 |
0.03 ± 0.02 |
.4793 |
| OER |
0.35 ± 0.03 |
0.35 ± 0.03 |
.9928 |
-0.1 ± 0.03 |
-0.03 ± 0.01 |
.0160 |
Kumar et al. Critical Care 2008 12:R35 doi:10.1186/cc6814 |
||||||